Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Lindsay Partridge Reflects on 25 Years as Brickworks CEO Ahead of Retirement | Lindsay Partridge - CEO of brickworks ltd
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Lindsay Partridge is the CEO of brickworks ltd
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Lexington Gold Upgrades Resource at Jones-Keystone Loflin, Assay Results from Argo Asset Show Promise | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Discover Your Path to Financial Freedom with 2.0 Financial
00:10:00
Uncovering Investment Opportunities Across Key Sectors
00:10:00
Insights from Daivis Virbickas, CEO of electricity transmission company Litgrid, on the company's business plans at a securities exchange event.
00:10:00
We extremely responsive to our borrower's needs.|Samir Patel,Managing Partner,Trophy Point Capital, LLC
00:10:00
Quick Guide to Navigating the Monex Securities Website
00:10:00
Antler specializes in local Founder Residencies, and invests in founders across industries|Ollie Forsyth,Global Community Manager,Antler
00:10:00
Innovative Middle Market Deal Structures: Sector-Specific Strategies Drive Success, Says Expert|Michael J. Kluger, Managing Director, Altaris Capital
00:10:00
Adapting to New Business Realities in South Africa: Challenges and Resilience Amid Logistics and Energy Constraints|DR NOMBASA TSENGWA,CHIEF EXECUTIVE OFFICER,Exxaro Resources Ltd.
00:10:00
Managing the Stress of the Sandwich Generation: Balancing Family, Retirement, and Elder Care | Ron Bernstein, Co-Founder, Prism Planning Partners, LLC.
00:10:00
Tele2 CEO anticipates that the pandemic will accelerate the company's utilization of digital channels and artificial intelligence.|Kjell Morten Johnsen, president and CEO of Tele2
00:10:00
Intellectual Property Battles: Anglo-American Power Shift in Defense Technology|Katherine C. Epstein